<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34192271</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2633-6960</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Oxford open immunology</Title><ISOAbbreviation>Oxf Open Immunol</ISOAbbreviation></Journal><ArticleTitle>What can neuroimmunology teach us about the symptoms of long-COVID?</ArticleTitle><Pagination><StartPage>iqab004</StartPage><MedlinePgn>iqab004</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">iqab004</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/oxfimm/iqab004</ELocationID><Abstract><AbstractText>Long-Coronavirus Disease (Long-COVID) is becoming increasingly recognized due to the persistence of symptoms such as profound fatigue, neurocognitive difficulties, muscle pains and weaknesses and depression, which would last beyond 3-12 weeks following infection with SARS-CoV-2. These particular symptoms have been extensively observed and studied in the context of previous psychoneuroimmunology research. In this short commentary, we discuss how previous neuroimmunology studies could help us to better understand pathways behind the development of these prolonged symptoms. Various mechanisms, including viral neuroinvasion, glial cells activation, neurogenesis, oxidative stress have been shown to explain these symptoms in the context of other disorders. Previous neuroimmunology findings could represent helpful pointers for future research on long-COVID symptoms and suggest potential management strategies for patients suffering with long-COVID.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mondelli</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-8690-6839</Identifier><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pariante</LastName><ForeName>Carmine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRF_MRF-160-0005-ELP-MONDE</GrantID><Acronym>MRF</Acronym><Agency>MRF</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oxf Open Immunol</MedlineTA><NlmUniqueID>101770669</NlmUniqueID><ISSNLinking>2633-6960</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">neuroimmunology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>17</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34192271</ArticleId><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="doi">10.1093/oxfimm/iqab004</ArticleId><ArticleId IdType="pii">iqab004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M &#xa0;et al. &#xa0;Management of post-acute covid-19 in primary care. BMJ &#xa0;2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>
Study CS. &#xa0;How Long Does COVID-19 Last? https://covid.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI- (6 June 2020, date last accessed).</Citation></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA &#xa0;2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C &#xa0;et al. &#xa0;Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun &#xa0;2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O'Connor JC, Freund GG &#xa0;et al. &#xa0;From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci &#xa0;2008;9:46&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison CL, Lin JM, Reeves WC. &#xa0;Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun &#xa0;2009;23:327&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">19111923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V, Vernon AC, Turkheimer F &#xa0;et al. &#xa0;Brain microglia in psychiatric disorders. Lancet Psychiatry &#xa0;2017;4:563&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28454915</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A, Hepgul N, Nikkheslat N &#xa0;et al. &#xa0;Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology &#xa0;2019;100:276&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht DS, Forsberg A, Sandstrom A &#xa0;et al. &#xa0;Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain Behav Immun &#xa0;2019;75:72&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6541932</ArticleId><ArticleId IdType="pubmed">30223011</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsland AL, Gianaros PJ, Kuan DC &#xa0;et al. &#xa0;Brain morphology links systemic inflammation to cognitive function in midlife adults. Brain Behav Immun &#xa0;2015;48:195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4508197</ArticleId><ArticleId IdType="pubmed">25882911</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumeister D, Russell A, Pariante CM &#xa0;et al. &#xa0;Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol &#xa0;2014;49:841&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24789456</ArticleId></ArticleIdList></Reference><Reference><Citation>Enache D, Pariante CM, Mondelli V. &#xa0;Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun &#xa0;2019;81:24&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">31195092</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L &#xa0;et al. &#xa0;The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain &#xa0;2020;143:3104&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D &#xa0;et al. &#xa0;Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry &#xa0;2020;7:611&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z &#xa0;et al. &#xa0;Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun &#xa0;2020;87:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalicova A, Bhide K, Bhide M &#xa0;et al. &#xa0;How viruses infiltrate the central nervous system. Acta Virol &#xa0;2017;61:393&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">29186956</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Fu L, Gonzales DM &#xa0;et al. &#xa0;Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virol &#xa0;2004;78:3398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC371061</ArticleId><ArticleId IdType="pubmed">15016862</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, Lutgehetmann M, Lindenmeyer MT &#xa0;et al. &#xa0;Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med &#xa0;2020;383:590&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S &#xa0;et al. &#xa0;Neuropathological features of Covid-19. N Engl J Med &#xa0;2020;383:989&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B &#xa0;et al. &#xa0;Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv &#xa0;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, Lutgehetmann M, Hagel C &#xa0;et al. &#xa0;Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol &#xa0;2020;19:919&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Valnet R, Pizzarotti B, Anichini A &#xa0;et al. &#xa0;Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol &#xa0;2020;27:e43&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267660</ArticleId><ArticleId IdType="pubmed">32383343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M, Ren Y, Lv T. &#xa0;Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun &#xa0;2020;88:945&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146652</ArticleId><ArticleId IdType="pubmed">32283294</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger JC,, Li L, Marvar PJ &#xa0;et al. &#xa0;Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun &#xa0;2013;31:153&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3578984</ArticleId><ArticleId IdType="pubmed">23072726</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini A, Cattaneo A, Malpighi C &#xa0;et al. &#xa0;Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms. Int J Neuropsychopharmacol &#xa0;2018;21:187&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793815</ArticleId><ArticleId IdType="pubmed">29040650</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini A, Di Benedetto MG, Giacobbe J &#xa0;et al. &#xa0;Pro- and anti-inflammatory properties of interleukin (IL6) in vitro: relevance for major depression and for human hippocampal neurogenesis. Int J Neuropsychopharmacol &#xa0;2020;23;738&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745251</ArticleId><ArticleId IdType="pubmed">32726406</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng LS, Kaneko N, Sawamoto K. &#xa0;Minocycline treatment ameliorates interferon-alpha-induced neurogenic defects and depression-like behaviors in mice. Front Cell Neurosci &#xa0;2015;9:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4309184</ArticleId><ArticleId IdType="pubmed">25674053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandiego CM, Gallezot JD, Pittman B &#xa0;et al. &#xa0;Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA &#xa0;2015;112:12468&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4603509</ArticleId><ArticleId IdType="pubmed">26385967</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettis MA, Veronese M, Nikkheslat N &#xa0;et al. &#xa0;PET imaging shows no changes in TSPO brain density after IFN-alpha immune challenge in healthy human volunteers. Trans Psychiatry &#xa0;2020;10:89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7063038</ArticleId><ArticleId IdType="pubmed">32152285</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell NG, Bouyagoub S, Tibble J &#xa0;et al. &#xa0;Interferon-alpha-induced changes in NODDI predispose to the development of fatigue. Neuroscience &#xa0;2019;403:111&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6458994</ArticleId><ArticleId IdType="pubmed">29292074</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison NA, Brydon L, Walker C &#xa0;et al. &#xa0;Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry &#xa0;2009;66:407&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885494</ArticleId><ArticleId IdType="pubmed">19423079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW &#xa0;et al. &#xa0;Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med &#xa0;2009;169:2142&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. &#xa0;Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol &#xa0;2011;11:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SE, Tosato G, Armstrong G &#xa0;et al. &#xa0;Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med &#xa0;1985;102:7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell S, Ray KK, Buckland M &#xa0;et al. &#xa0;Chronic fatigue syndrome and circulating cytokines: a systematic review. Brain Behav Immun &#xa0;2015;50:186&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">26148446</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN &#xa0;et al. &#xa0;Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA &#xa0;2017;114:E7150&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, Sartor ML, Scott F &#xa0;et al. &#xa0;Inflammatory proteins are altered in chronic fatigue syndrome-a systematic review and meta-analysis. Neurosci Biobehav Rev &#xa0;2019;107:69&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">31465778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ifuku M, Hossain SM, Noda M &#xa0;et al. &#xa0;Induction of interleukin-1beta by activated microglia is a prerequisite for immunologically induced fatigue. Eur J Neurosci &#xa0;2014;40:3253&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">25040499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AJM, Macedo DS, de Lucena DF &#xa0;et al. &#xa0;Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities. Behav Brain Res &#xa0;2019;372:111975.</Citation><ArticleIdList><ArticleId IdType="pubmed">31136774</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano GF, Tomassi S, Russell A &#xa0;et al. &#xa0;Fibromyalgia and chronic fatigue: the underlying biology and related theoretical issues. Adv Psychosom Med &#xa0;2015;34:61&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">25832514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgidani M, Kato TA, Hosoi M &#xa0;et al. &#xa0;Fibromyalgia and microglial TNF-alpha: translational research using human blood induced microglia-like cells. Sci Rep &#xa0;2017;7:11882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605512</ArticleId><ArticleId IdType="pubmed">28928366</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CR, Andriessen AS, Chen G &#xa0;et al. &#xa0;Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics &#xa0;2020;17:846&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7609632</ArticleId><ArticleId IdType="pubmed">32820378</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay ME, Madore C, Bordeleau M &#xa0;et al. &#xa0;Neuropathobiology of COVID-19: the role for glia. Front Cell Neurosci &#xa0;2020;14:592214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies V, Lyon DE, Elswick RK Jr &#xa0;et al. &#xa0;Psychoneuroimmuno-logical relationships in women with fibromyalgia. Biol Res Nurs &#xa0;2013;15:219&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722552</ArticleId><ArticleId IdType="pubmed">22174319</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K &#xa0;et al. &#xa0;Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One &#xa0;2020;15:e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayley S, Hakim AM, Albert PR. &#xa0;Depression, dementia and immune dysregulation. Brain &#xa0;2020. 10.1093/brain/awaa405</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa405</ArticleId><ArticleId IdType="pmc">PMC8041341</ArticleId><ArticleId IdType="pubmed">33279966</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkheimer FE, Althubaity N, Schubert J &#xa0;et al. &#xa0;Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression. Brain Behav Immun &#xa0;2020;91:487&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">33160089</ArticleId></ArticleIdList></Reference><Reference><Citation>Yirmiya R, Goshen I. &#xa0;Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun &#xa0;2011;25:181&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">20970492</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. &#xa0;Role of the kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches. Curr Top Behav Neurosci &#xa0;2017;31:117&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6585430</ArticleId><ArticleId IdType="pubmed">27225497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sforzini L, Nettis MA, Mondelli V &#xa0;et al. &#xa0;Inflammation in cancer and depression: a starring role for the kynurenine pathway. Psychopharmacology (Berl) &#xa0;2019;236:2997&#x2013;3011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6820591</ArticleId><ArticleId IdType="pubmed">30806743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O'Connor JC, Lawson MA &#xa0;et al. &#xa0;Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology &#xa0;2011;36:426&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053088</ArticleId><ArticleId IdType="pubmed">21041030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepgul N, Cattaneo A, Agarwal K &#xa0;et al. &#xa0;Transcriptomics in interferon-alpha-treated patients identifies inflammation-, neuroplasticity- and oxidative stress-related signatures as predictors and correlates of depression. Neuropsychopharmacology &#xa0;2016;41:2502&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4983179</ArticleId><ArticleId IdType="pubmed">27067128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakunina N, Pariante CM, Zunszain PA. &#xa0;Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology &#xa0;2015;144:365&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557673</ArticleId><ArticleId IdType="pubmed">25580634</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan J, Jamshed H, Qureshi H. &#xa0;Early detection and prevention of Alzheimer's disease: role of oxidative markers and natural antioxidants. Front Aging Neurosci &#xa0;2020;12:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397955</ArticleId><ArticleId IdType="pubmed">32848710</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison CL, Rutherford RE, Woolwine BJ &#xa0;et al. &#xa0;A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry &#xa0;2013;70:31&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015348</ArticleId><ArticleId IdType="pubmed">22945416</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariante CM. &#xa0;Psychoneuroimmunology or immunopsychiatry? &#xa0;Lancet Psychiatry &#xa0;2015;2:197&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4580988</ArticleId><ArticleId IdType="pubmed">26359887</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty GD, Deary IJ, Luciano M &#xa0;et al. &#xa0;Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. Brain Behav Immun &#xa0;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297693</ArticleId><ArticleId IdType="pubmed">32561221</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>